Pivotal Bio Venture Partners Investment Advisor LLC Recursion Pharmaceuticals, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $71.5 Million
- Q1 2025
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 595,518 shares of RXRX stock, worth $3.86 Million. This represents 4.41% of its overall portfolio holdings.
Number of Shares
595,518
Previous 595,518
-0.0%
Holding current value
$3.86 Million
Previous $4.03 Million
21.74%
% of portfolio
4.41%
Previous 3.7%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
358Shares Held
285MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$226 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$210 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$158 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$112 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$95.2 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.17B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...